Phocas Financial Corp’s AdaptHealth AHCO Stock Holding History

Phocas Financial Corp’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-204,660	Closed	-$2.54M	–	186
2023 Q1	$2.54M	Buy	+204,660	New	+$3.77M	0.36%	110

Other funds holding AHCO

OCA

OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Phocas Financial Corp's AHCO Position: Q2 2023 in Review

Phocas Financial Corp sold out of AdaptHealth (AHCO) in Q2 2023, closing a stake of 204,660 shares — an estimated $2.54M sold.

Phocas Financial Corp first reported a position in AHCO in Q1 2023 and held it in 1 quarter. The position peaked at $2.54M in Q1 2023. 182 funds tracked by Wall St. Rank hold AHCO as of Q2 2023.

Phocas Financial Corp reported no remaining AdaptHealth position as of Q2 2023 after selling out during the quarter.
Phocas Financial Corp sold 204,660 AdaptHealth shares in Q2 2023, an estimated $2.54M.
Phocas Financial Corp first reported a position in AdaptHealth in Q1 2023 and held it in 1 quarter.
Phocas Financial Corp's AdaptHealth position peaked at $2.54M in Q1 2023.
182 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2023.

Based on Phocas Financial Corp's 13F filing for Q2 2023, filed 13 Jul 2023.